AstraZeneca PLC (AZN)
93.63
-1.02
(-1.08%)
USD |
NASDAQ |
Jan 12, 16:00
93.60
-0.03
(-0.03%)
After-Hours: 20:00
AstraZeneca Research and Development Expense (Quarterly): 3.530B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GSK Plc | 2.124B |
| Amgen, Inc. | 1.90B |
| Gilead Sciences, Inc. | 1.334B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Sanofi | -- |